Return to work two years after diagnosis associated with higher cognitive speed performance before and after cancer treatment.

A retrospective study of patients with lymphoma identified risk factors for clinically significant CMV infection in this patient population.

The CCL17/CCL22-CCR4 axis can be used as a novel biomarker for the prognosis of B-cell acute lymphoblastic leukemia (ALL), according to a new study published in the journal Cytokine. It is already ...

Researchers say the data indicate cancer cases continued to be underdiagnosed in the second year of the pandemic.